<p>If signs of virilisation develop, discontinuation of the treatment should be considered, preferably in consultation with the patient.<br />
<br />
It is recommended to monitor patients with any of the following conditions:</p>

<ul>
	<li>latent or overt cardiac failure, renal dysfunction, hypertension of migraine (or a history of these conditions), since anabolic steroids may occasionally induce fluid retention</li>
	<li>incomplete statural growth, since anabolic steroids in high dosages may accelerate epiphyseal closure skeletal metastases of breast carcinoma. In these patients</li>
	<li>hypercalcaemia may develop both spontaneously and as a result of anabolic steroid therapy. The later can be indicative of a positive tumour response to the hormonal treatment. Nevertheless, the hypercalcaemia should first be treated appropriately and after restoration of normal calcium levels hormone therapy can be resumed</li>
	<li>liver dysfunction</li>
</ul>

<p>The use of anabolic steroids to enhance athletic ability may carry severe risks to the user&#39;s health and should be discouraged</p>